Avanos Medical AVNS Effect of dilutive RSUs and PSUs (in shares)
Effect of dilutive RSUs and PSUs (in shares) at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's effect of dilutive rsus and psus (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's effect of dilutive rsus and psus (in shares)?
- Avanos Medical (AVNS) reported effect of dilutive rsus and psus (in shares) of 1M in Q1 2026.
- How has Avanos Medical's effect of dilutive rsus and psus (in shares) changed year-over-year?
- Avanos Medical's effect of dilutive rsus and psus (in shares) increased by 42.9% year-over-year, from 700K to 1M.
- What is the long-term trend for Avanos Medical's effect of dilutive rsus and psus (in shares)?
- Over 4 years (2021 to 2025), Avanos Medical's effect of dilutive rsus and psus (in shares) has grown at a -8.5% compound annual growth rate (CAGR), from 1M to 700K.
- What does effect of dilutive rsus and psus (in shares) mean?
- The incremental number of shares that would be issued if all outstanding restricted stock units (RSUs) and performance stock units (PSUs) were converted into common stock. This metric quantifies the potential dilution to existing shareholders from equity-based incentive plans.